Jardiance may cause mild side effects other than those listed above. See the drug’s prescribing information for details. Jardiance may cause serious side effects. The following list may not ...

Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at one-tenth of the original cost.

Jardiance from Boehringer Ingelheim is used ... went on for months after the CMS selected 10 high-priced, single-source drugs that didn't have generic or competitor versions to renegotiate under ...

Eli Lilly and Boehringer Ingelheim's blockbuster diabetes drug Jardiance (empagliflozin) has been granted approval by the US Food and Drug Administration (FDA) for a wider range of heart failure ...

After many months of closely watched negotiations, the Centers for Medicare & Medicaid Services (CMS) announced the list of negotiated prices for 10 drugs. This marks the first set of negotiations ...

An oral SGLT2 inhibitor, Jardiance (empagliflozin) is in competition with other drugs in its class, such as J&J’s Invokana and AstraZeneca’s Forxiga, but now looks set to become the market ...

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 ...

The National Pharmaceutical Pricing Authority (NPPA) has fixed prices of 80 new drugs including anti-diabetes, anti-hypertension, pain relief formulations from major pharmaceutical companies, in its ...

Empagliflozin is sold under the brand name Jardiance. “Empagliflozin belongs to the SGLT-2i group of drugs. (Sodium glucose transporter inhibitor) drugs. These drugs have shown multiple benefits ...